Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
12.8M
-
Shares change
-
+5.06M
-
Total reported value, excl. options
-
$1.19B
-
Value change
-
+$475M
-
Put/Call ratio
-
0.83
-
Number of buys
-
108
-
Number of sells
-
-33
-
Price
-
$92.60
Significant Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q1 2015
159 filings reported holding ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2015.
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.8M shares
of 207M outstanding shares and own 6.17% of the company stock.
Largest 10 shareholders include FMR LLC (2.19M shares), Visium Asset Management, LP (1.4M shares), Pentwater Capital Management LP (1.3M shares), GILDER GAGNON HOWE & CO LLC (806K shares), WASATCH ADVISORS INC (756K shares), VANGUARD GROUP INC (396K shares), STATE STREET CORP (393K shares), Polar Capital LLP (377K shares), COLUMBUS CIRCLE INVESTORS (247K shares), and GRANAHAN INVESTMENT MANAGEMENT INC/MA (233K shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.